Parkinson's Disease Clinical Trial
Official title:
Development of Parkinson's Glove for Detection and Suppression of Hand Tremor at Rest Among the Tremor-predominant Parkinson's Disease Patients With Medically Intractable Tremor
This study is aimed to study the feasibility and safety of parkinson's glove that combined 2 module of tremor detection and tremor suppression with electrical muscle stimulation for using as device for rest tremor suppression in parkinson's disease patients
Study Population
1. Target: Thai Parkinson's disease (PD) patients with predominant rest tremor : 50
patients
2. Population sample: Patients who are getting their treatment at the Chulalongkorn
Comprehensive Movement Disorder Clinic at King Chulalongkorn Memorial Hospital.
Study methods as follows:
- All PD subjects will be provided the information on this research study and informed
consent will be sought for every subjects.
- All PD subjects will be interviewed by a movememt disorders specialist or a trained
interviewer for their demographic and clinical data.
- All PD patients will be examined for the severity of Parkinson's disease by a movement
disorders specialist according the Unified Parkinson's disease Rating Scale (UPDRS),
Hoehn and Yahr score, and tremor rating scale during the 'on period' in order to
determine the additional effect of parkinson's glove and sham glove for suppression of
tremor
- All PD patients will be randomly allocated into 2 groups (25 Parkinson's glove and 25
sham glove) with block randomization method.
- All patients will get Parkinson's glove for home-based usage for 14 days, the
appointment for follow -up will be done for 4 times, with once daily phone call from
investigators in order to check for improvement symptoms and all adverse events such as
pain will be recorded and determined it severity by the visual analog scale.
Data collection
- Demographic and clinical data: age, gender, clinical diagnosis, tremor rating scale,
pain score by visual analog scale , Parkinson's disease's severity score for each
subject according to establishing standard rating scale.
- Tremor parameters form Parkinson's glove will be collected in SD card as 5 parameters:
Peak magnitude, RMS, Angle, Frequency, Q. Number of stimulation times will be recorded.
Data analysis The statistical analysis in this study is based from SPSS program version 17.
Categorical data will be analyzed for frequency and percentage. Continuous data will be
analyzed by mean and standard deviation (SD). Non-parametric study would be preferred if the
small sample size or in case of distribution of data do not present as normal distribution
(determined by Kolmogorov-Smirnov test). The repeated ANOVA will be used for determined the
efficacy of parkinson's glove in the difference times in follow up periods.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Terminated |
NCT02894567 -
Evaluation of Directional Recording and Stimulation Using spiderSTN
|
N/A | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A |